所有图片(1)

主要文件

COO原产地证书/COA分析证书

安全信息

安全和法规

B1040000

Betamethasone dipropionate

Name: Betamethasone dipropionate
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

别名:

Betamethasone 17,21-dipropionate, 9α-Fluoro-16β-methyl-11β,17α,21-trihydroxy-1,4-pregnadiene-3,20-dione 17,21-dipropionate

登录查看公司和协议定价

所有图片(1)

About This Item

经验公式（希尔记法）:

C₂₈H₃₇FO₇

CAS号:

5593-20-4

分子量:

504.59

MDL编号:

MFCD00133140

UNSPSC代码:

41116107

PubChem化学物质编号:

329773156

NACRES:

NA.24

推荐产品

Slide 1 of 10

1 of 10

Supelco

PHR1399

二丙酸倍他米松

USP

1067704

Betamethasone dipropionate

B1000000

倍他米松

BP042

戊酸倍他米松

Supelco

PHR1398

倍他米松

Y0001416

Betamethasone dipropionate for peak identification

Sigma-Aldrich

B1152

Betamethasone 17,21-dipropionate

USP

1141002

克霉唑

Supelco

PHR1780

倍他米松 17-戊酸酯

USP

1066009

倍他米松

等级

pharmaceutical primary standard

API类

betamethasone

制造商/商品名称

EDQM

应用

pharmaceutical (small molecule)

包装形式

neat

SMILES字符串

[H][C@@]12C[C@H](C)[C@](OC(=O)CCl)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)C3(F)[C@@]2([H])CCC4=CC(=O)C=C[C@]34C

InChI

1S/C27H34ClFO7/c1-5-22(33)35-14-21(32)27(36-23(34)13-28)15(2)10-19-18-7-6-16-11-17(30)8-9-24(16,3)26(18,29)20(31)12-25(19,27)4/h8-9,11,15,18-20,31H,5-7,10,12-14H2,1-4H3/t15-,18-,19-,20-,24-,25-,26?,27-/m0/s1

InChI key

UOCNBCVPZWLUKX-HOBFILNXSA-N

正在寻找类似产品? 访问产品对比指南

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Betamethasone dipropionate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生化/生理作用

Betamethasone 17,21-dipropionate is a glucocorticoid with anti-inflammatory and immunosuppressive activity.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

1067045

1067726

Betamethasone Dipropionate Related Compound B, United States Pharmacopeia (USP) Reference Standard

1067737

Betamethasone Dipropionate Related Compound C, United States Pharmacopeia (USP) Reference Standard

1067760

Betamethasone Dipropionate Related Compound F , United States Pharmacopeia (USP) Reference Standard

1067781

Betamethasone dipropionate Related Compound H, United States Pharmacopeia (USP) Reference Standard

象形图

GHS08

警示用语：

Danger

危险声明

H360FD,H373

预防措施声明

P202 - P260 - P280 - P308 + P313 - P405 - P501

危险分类

Repr. 1B - STOT RE 2

靶器官

Liver,Kidney,Endocrine system

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

监管及禁止进口产品

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number

抱歉，我们目前尚未线上提供该产品的COA。

如需帮助，请联系客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

The effects of betamethasone dipropionate and fish oil on HaCaT proliferation and apoptosis.

Mohd Hanif Zulfakar et al.

International journal of pharmaceutics, 434(1-2), 399-405 (2012-06-14)

The current work examined the effect of fish oil (FO) and betamethasone dipropionate (BD) on the growth of immortalized HaCaT keratinocytes. HaCaT cells were grown and treated with FO and/or BD, and proliferation determined using the MTT method. The cells

Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis.

Naresh Punwani et al.

Journal of the American Academy of Dermatology, 67(4), 658-664 (2012-01-28)

Janus-associated kinases (JAKs) are involved in signal transduction from a variety of cytokines implicated in the pathogenesis of psoriasis, including interleukin (IL)-12, IL-23, and interferon-γ. INCB018424, a small molecule inhibitor of JAK1 and JAK2, inhibits cytokine-induced JAK/signal transducers and activators

Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.

Susana Coimbra et al.

American journal of clinical dermatology, 13(1), 37-47 (2011-09-06)

A few studies in psoriasis vulgaris patients have reported changes suggesting red blood cell (RBC) damage is linked to neutrophil activation, oxidative stress, and psoriasis worsening. The aim of this study was to evaluate erythroid disturbances in Portuguese psoriasis vulgaris

Local steroid therapy as the first-line treatment for boys with symptomatic phimosis - a long-term prospective study.

Srinath Reddy et al.

Acta paediatrica (Oslo, Norway : 1992), 101(3), e130-e133 (2011-11-23)

Phimosis is a common paediatric urological disorder and often necessitates circumcision. We prospectively evaluated local steroid therapy (LST) as the first choice therapy for such children. Two hundred and sixty symptomatic boys up to 15 years of age (mean 34

Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.

Leon H Kircik

Journal of drugs in dermatology : JDD, 10(8), 878-882 (2011-08-06)

Etanercept is approved for the treatment of plaque psoriasis at a subcutaneous (SC) dosage of 50 mg twice-weekly for three months, followed by 50 mg SC once-weekly thereafter. It is of note, however, that many patients experience loss of efficacy

查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门

主要文件

安全信息

Betamethasone dipropionate

European Pharmacopoeia (EP) Reference Standard

About This Item

推荐产品

属性

等级

API类

制造商/商品名称

应用

包装形式

SMILES字符串

InChI

InChI key

相关类别

说明

一般描述

应用

生化/生理作用

包装

其他说明

相关产品

相关产品

安全信息

象形图

警示用语：

危险声明

预防措施声明

危险分类

靶器官

储存分类代码

WGK

闪点(°F)

闪点(°C)

法规信息

文件

分析证书(COA)

已有该产品？

同行评审论文

技术服务